The method assesses growth rates of the tumour and detects gene patterns that can forecast outcomes of the patient.

Farber Cancer Institute have developed a blood test that could transform the diagnosis and monitoring of multiple myeloma (MM) and its precursor conditions. The new method, known as SWIFT-seq, ...